Summary
- Braskem faces financial strain from an R$8 billion indemnity claim filed by Novonor
- Enforcing the judgment could jeopardize Braskem’s financial stability and ability to meet obligations under leniency agreements
- The legal battle highlights broader struggles within Novonor and may impact investor confidence
- The resolution of this case could set a precedent for companies with complex ownership structures
